Factores asociados a mortalidad en pacientes Covid-19 en un Hospital del norte de Perú

Murrugarra-Suarez, Saúl; Loza, Miryam Griselda Lora; Paredes, José Elías Cabrejo; Mucha-Hospinal, Luis; Fernandez-Cosavalente, Hugo

doi:10.35434/rcmhnaaa.2020.134.773

Cited by 11 publications

(10 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Este estudio difiere significativamente de lo reportado en hospitales públicos del Perú, por ejemplo en la zona norte (Trujillo) se halló una letalidad intrahospitalaria por COVID-19 entre 40.28 % [19] y 46.2 % [20] ; en el sur del país (Tacna), Hueda et al reportaron una letalidad de 32.9 %, en dicho estudio 70 % de los pacientes ingresó con una SatO < 90 % y el 73 % de los que requerían UCI ingresaron a dicha unidad [17] .…”

Section: Discussionunclassified

Letalidad por COVID-19 en adultos hospitalizados durante las dos primeras olas pandémicas: Una experiencia del sector privado en Perú

et al. 2023

View full text Add to dashboard Cite

Introducción: La letalidad por COVID-19 en Perú fue 9.1% en 2020-2021, una de la más altas en el mundo. Objetivos: describir la letalidad por COVID-19 en adultos hospitalizados en una clínica privada en Lima, Perú durante las primeras dos olas pandémicas y evaluar sus factores asociados. Materiales y métodos: Estudio trasversal analítico en abril-septiembre 2020 (primera ola) y enero-mayo 2021 (segunda ola), en pacientes mayores de 18 años atendidos por COVID-19 en una clínica privada del Perú, obtenidos por muestreo aleatorio simple. Se aplicó pruebas estadísticas considerando p<0,05, usando IBM SPSS 27.0. Resultados: La muestra de 263 y 235 pacientes en la primera y segunda ola, la mediana de edad fue 51 y 49 años en cada periodo y en ambos momentos el sexo masculino predominó con 72.9% y 63.2%. La letalidad fue de 7.7% y 6% en cada ola pandémica. Entre ambas olas se encontró diferencia respecto al sexo y frecuencia respiratoria. Los factores asociados a letalidad en ambas olas fueron la edad, SatO/FiO y lactato deshidrogenasa (LDH). Conclusiones: La letalidad por COVID-19 en pacientes adultos hospitalizados en una clínica privada, durante las primeras dos olas pandémicas fue baja y los factores asociados fueron edad, SatO/FiO y LDH.

show abstract

Section: Discussionunclassified

Letalidad por COVID-19 en adultos hospitalizados durante las dos primeras olas pandémicas: Una experiencia del sector privado en Perú

et al. 2023

View full text Add to dashboard Cite

show abstract

“…In Spain, for example, there have been more cases of COVID-19 in women than in men (10); however, there is a lower percentage of lethality in women (11). In Latin American countries such as Argentina, Mexico, Colombia and Peru, the highest number of confirmed cases corresponds to males (12,13,14,15).…”

Section: Discussionmentioning

confidence: 99%

Clinical-epidemiological characterization of adult women diagnosed with COVID-19 in a hospital in northern Peru

2022

pnr

View full text Add to dashboard Cite

Objective: to describe the clinical-epidemiological characteristics of adult women with COVID-19 diagnosis in an EsSalud Cajamarca Hospital during 2020 -2021. Method: the methodology is descriptive, retrospective, observational and cross-sectional. The population consisted of adult women, and the sample consisted of 216 women. A data collection form was applied to the NOTI COVID registry and the clinical history was used. Results: Of the 216 confirmed cases, 67.6% of the cases were women between 30 and 49 years of age. Ninetyseven percent were from the department of Cajamarca. Of these, 11.2% were pregnant women, 58.3% of whom were in the third trimester of pregnancy. More than half (81.1%) had a positive serologic test result, and 50.9% were IgG. Of the COVID-19 women, 41.7% had contact with a positive case and only 0.9% had contact with a suspected COVID-19 case. The most frequent comorbidities were arterial hypertension (21.2%), diabetes (15.4%) and obesity (13.5%). The degree of severity was mostly mild (57.9%), they presented general malaise (14.3%), and cough (13.3%). 63.5% presented interstitial ground-glass pattern and 34.9% presented hypertransaminasemia and 27.9% lymphopenia. Conclusions: adult women with a COVID-19 diagnosis had comorbidities such as hypertension, diabetes and obesity.

show abstract

“…The study shows the characteristics of the Peruvian population with COVID-19 infection that received oxygen therapy through HFNC during the second wave of the pandemic and is one of the few studies that analyzes the factors associated with the failure of the use of this device in this population, where the lethality was between 40 and 46% during the rst two waves (42,43). In addition, our study includes an analysis of several clinical and laboratory variables and oxygenation parameters during follow-up, thus allowing us to evaluate the implications of these variables through multivariate analysis.…”

Section: Strengths the Studymentioning

confidence: 99%

Predictors of high-flow nasal cannula failure in COVID-19 patients in a northern Peruvian hospital.

Calle-Peña,

Tavara,

Aguirre-Milachay

et al. 2024

Preprint

View full text Add to dashboard Cite

Objectives: To determine the predictors of high-flow nasal cannula (HFNC) failure in COVID-19 patients in a hospital in northern Peru. Methodology: A retrospective cohort study was conducted during the months of March and May 2021. Data collection was based on a follow-up of 156 hospitalized patients with a diagnosis of COVID-19 who were users of HFNC, and outcomes and factors were analyzed from medical records. Epidemiological, analytical, and HFNC use-related characteristics were described using measures of absolute and relative frequencies, measures of central tendency, and dispersion. A multivariate Poisson regression analysis with robust variance and a 95% confidence interval was performed. Results: We found that age, SpO2/FiO2 and work of breathing (WOB) at admission, degree of involvement and type of infiltrate on CT scan, lymphocytes, c-reactive protein, and D-dimer were significantly associated with failure of HFNC (p< 0.05). In addition, WOB, PaO2/FiO2, SaO2/FiO2, and ROX index were variables that presented statistical significance (p<0.0001). In the multivariate analysis model, a risk of failure of HFNC was determined with age >= 60 years [RRa 1.39 (1.05–1.85)] and PaO2/FiO2 score less than 100 [RRa 1.65 (0.99–2.76)]. Conclusions: Predictors to failure of HFNC are age older than 60 years and minimally significantly lower PaO2/FiO2 than 100.

show abstract

Factores asociados a mortalidad en pacientes Covid-19 en un Hospital del norte de Perú

Cited by 11 publications

References 0 publications

Letalidad por COVID-19 en adultos hospitalizados durante las dos primeras olas pandémicas: Una experiencia del sector privado en Perú

Letalidad por COVID-19 en adultos hospitalizados durante las dos primeras olas pandémicas: Una experiencia del sector privado en Perú

Clinical-epidemiological characterization of adult women diagnosed with COVID-19 in a hospital in northern Peru

Predictors of high-flow nasal cannula failure in COVID-19 patients in a northern Peruvian hospital.

Contact Info

Product

Resources

About